S9E-38346-58343
4 vaccinations
1 coded response
40 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 603 / IL
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
-
2021-02-20
Dose 2 — Pfizer-BioNTech
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-05-22
- 2021-08-22
- 2022-02-20
-
2022-09-24
Dose 3 — Pfizer-BioNTech
-
2022-09-26
Dose 4 — Pfizer-BioNTech
-
2022-09-26
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-27
- 2022-09-28
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-11
- 2022-10-17
- 2022-10-24
- 2022-10-31
-
2022-11-07
Survey response — day 42, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-26
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2022-09-24 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Pfizer-BioNTech | No |
Free text
Release 12 — day 42, dose 4
Symptoms: Sore throat, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release